Skip to main content

Table 6 Analysis of cost per patient (€, 2011)

From: Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

  Non-exposed group Exposed group Difference
Base case
Cost of ART during the study period* 3,017.50 2,873.58 143.92
Cost of AEs during the study period 0.00 230.26 −230.26
Average total cost during the study period 3,017.50 3,103.84 −86.34
Total cost per day 25.22 25.94 −0.72
Alternative scenario
Cost of ART during the study period 3,017.50 2,873.58 143.92
Cost of AEs during the study period 0.00 230.26 −230.26
Cost of extra follow-up visit during the study period 0.00 345.83 −345.83
Total cost during the study period 3,017.50 3,449.67 −432.17
Total cost per day 25.22 28.83 −3.61
  1. *Study period = 120 days; ART: antiretroviral therapy; AEs: adverse events.